Literature DB >> 8323987

Prevalence of alcohol and drug abuse in schizophrenic inpatients.

M Soyka1, M Albus, N Kathmann, A Finelli, S Hofstetter, R Holzbach, B Immler, P Sand.   

Abstract

All schizophrenic patients admitted consecutively either to the Psychiatric Hospital of the University of Munich (group 1, N = 183) or the Mental State Hospital Haar/Munich (group 2, N = 447) between 1.8.1989 and 1.2.1990 were examined to assess prevalence estimates for substance abuse in schizophrenic inpatients. Psychiatric diagnosis were made according to ICD-9 criteria. Psychopathology and psychosocial variables were documented by means of the AMDP-protocol on admission and discharge. The diagnostic procedure included a detailed semi-structured interview concerning the individual alcohol and drug history and sociodemographic data, the Munich Alcoholism Screening Test (MALT), a physical examination and the screening of various laboratory parameters such as GGT and MCV, among others. The results show that substance abuse is a very common problem in schizophrenics. Lifetime prevalence rates for substance abuse were estimated at 21.8% in group 1 and 42.9% in group 2, 3-month prevalence rates for substance abuse were estimated at 21.3% resp. 29.0%. Alcohol abuse was by far the most common type of abuse with prevalence estimates being 17.4% resp. 34.6%. Prevalence rates for substance abuse were much higher in the more "chronic"sample of the Mental State Hospital and in male patients. With respect to schizophrenic subtype few differences could be demonstrated with drug dependence being more common in patients with paranoid schizophrenia. The MALT proved to be a valuable screening instrument for alcohol abuse in schizophrenics with both a high specificity and sensitivity. "Dual diagnosis" schizophrenics had a significantly higher rate of suicide attempts and were less likely to be married. Possible clinical implications of these findings are discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8323987     DOI: 10.1007/bf02190250

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  79 in total

1.  Substance use in young adults with schizophrenic disorders.

Authors:  M A Test; L S Wallisch; D J Allness; K Ripp
Journal:  Schizophr Bull       Date:  1989       Impact factor: 9.306

Review 2.  Alcoholism and suicide.

Authors:  A Roy; M Linnoila
Journal:  Suicide Life Threat Behav       Date:  1986

3.  Alcoholism and schizophrenia in Irishmen in London.

Authors:  C Bagley; A Binitie
Journal:  Br J Addict Alcohol Other Drugs       Date:  1970-05

4.  Psychopathology in hospitalized alcoholics.

Authors:  M N Hesselbrock; R E Meyer; J J Keener
Journal:  Arch Gen Psychiatry       Date:  1985-11

Review 5.  Genetic and clinical implications of alcoholism and affective disorder.

Authors:  M A Schuckit
Journal:  Am J Psychiatry       Date:  1986-02       Impact factor: 18.112

6.  The cocaine experience: refuting the concept of a model psychosis?

Authors:  S B Unnithan; J C Cutting
Journal:  Psychopathology       Date:  1992       Impact factor: 1.944

7.  Identification of the alcoholic schizophrenic: use of clinical laboratory tests and the MAST.

Authors:  A M Toland; H B Moss
Journal:  J Stud Alcohol       Date:  1989-01

8.  Schizophrenia: lifetime co-morbidity in a community sample.

Authors:  R C Bland; S C Newman; H Orn
Journal:  Acta Psychiatr Scand       Date:  1987-04       Impact factor: 6.392

9.  Recent psychostimulant use in hospitalized schizophrenics.

Authors:  M L Richard; B I Liskow; P J Perry
Journal:  J Clin Psychiatry       Date:  1985-03       Impact factor: 4.384

10.  Alcohol use and abuse in schizophrenia. A prospective community study.

Authors:  R E Drake; F C Osher; M A Wallach
Journal:  J Nerv Ment Dis       Date:  1989-07       Impact factor: 2.254

View more
  27 in total

1.  Use of potentially abusive psychotropic substances in psychiatric inpatients.

Authors:  J Modestin; C Nussbaumer; K Angst; P Scheidegger; D Hell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

2.  The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders.

Authors:  D L Kelly; C S Myers; M T Abrams; S Feldman; J Park; R P McMahon; J-C Shim
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

3.  Illicit drug use in heavy smokers with and without schizophrenia.

Authors:  Kristen M Mackowick; Stephen J Heishman; Heidi J Wehring; Fang Liu; Robert P McMahon; Deanna L Kelly
Journal:  Schizophr Res       Date:  2012-05-14       Impact factor: 4.939

4.  Concurrent substance-related disorders and mental illness: the North American experience.

Authors:  Nady el-Guebaly
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

Review 5.  [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Authors:  T Wobrock; R D'Amelio; P Falkai
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

Review 6.  Assessment and intervention for the suicidal patient with schizophrenia.

Authors:  J M Harkavy-Friedman; E A Nelson
Journal:  Psychiatr Q       Date:  1997

7.  The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC).

Authors:  Giuseppe Carrà; Sonia Johnson; Paul Bebbington; Matthias C Angermeyer; Dirk Heider; Traolach Brugha; Jean-Michel Azorin; Mondher Toumi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-17       Impact factor: 5.270

8.  [Substance use associated disorders: frequency in patients with schizophrenic and affective psychoses].

Authors:  L Hermle; R Szlak-Rubin; K L Täschner; P Peukert; A Batra
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

9.  Prevalence of Substance Use in Patients Diagnosed with Schizophrenia.

Authors:  Yasemin Tekin Uludağ; Gülcan Güleç
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

10.  Two types of classification for male opioid dependence: identification of an opioid addict with depressive features.

Authors:  J Modestin; B Matutat; O Würmle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-29       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.